Nevada Assembly Bill 156 (AB156) is “an ACT relating to substance use disorders; providing for the separate accounting of certain money for the purchase of opioid antagonists; establishing the order in which a provider or program is required to prioritize persons for participation in certain publicly funded programs for the treatment of alcohol or other substance use disorders; authorizing a pharmacist to prescribe and dispense drugs for medication-assisted treatment of opioid use disorder and perform certain assessments under certain conditions; requiring certain health plans to include coverage for such drugs and assessments; prescribing certain requirements concerning the diagnosis and treatment of a patient with an opioid use disorder; and providing other matters properly relating thereto.”
Learning Objectives:
By the end of this course, participants will be able to:
- Understand Assembly Bill (AB) 156 and regulations promulgated by the Nevada Board of Pharmacy
- Describe the process in which a pharmacist obtains authorization to prescribe MOUD
Presented by: Yenh Long, Pharm.D., BCACP, Nevada Board of Pharmacy
Continuing Education Units: 1 CEU
This training is approved for continuing education by the boards listed here.
Funding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.